FDA Inspection 953479 — Christopher Chappel
The FDA completed an inspection of Christopher Chappel on Dec 17, 2015 in Kissimmee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kissimmee, FL (United States)
Additional Details
Clinical Investigator (CI)